Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancer
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Despite the important role of Th17 cells in the pathogenesis of many autoimmune diseases, their prevalence and the mechanisms by which they are generated and regulated in cancer remain unclear. Here, we report the presence of a high percentage of CD4(+) Th17 cells at sites of ovarian cancer, compared with a low percentage of Th17 cells in peripheral blood mononuclear cells from healthy donors and cancer patients. Analysis of cytokine production profiles revealed that ovarian tumor cells, tumor-derived fibroblasts, and antigen-presenting cells (APCs) secreted several key cytokines including IL-1beta, IL-6, TNF-alpha and TGF-beta, which formed a cytokine milieu that regulated and expanded human IL-17-producing T-helper (Th17) cells. We further show that IL-1beta was critically required for the differentiation and expansion of human Th17 cells, whereas IL-6 and IL-23 may also play a role in the expansion of memory Th17 cells, even though IL-23 levels are low or undetectable in ovarian cancer. Further experiments demonstrated that coculture of naïve or memory CD4(+) T cells with tumor cells, APCs, or both could generate high percentages of Th17 cells. Treatment with anti-IL-1 alone or a combination of anti-IL-1 and anti-IL-6 reduced the ability of tumor cells to expand memory Th17 cells. Thus, we have identified a set of key cytokines secreted by ovarian tumor cells and tumor-associated APCs that favor the generation and expansion of human Th17 cells. These findings should accelerate efforts to define the function of this important subset of CD4(+) T cells in the human immune response to cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, elevated IL-17 signature genes can be found in multiple human malignancies including cervical cancer, esophageal cancer, gastric cancer, hepatocellular carcinoma, and colorectal cancer (CRC)”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Miyahara et al., 2008
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151 · cited 1×
“Although a previous study showed a high proportion of CD4 Treg cells in ovarian cancer (9), we did not find a high percentage of Treg cells in these ovarian tumor-derived T cell populations (Fig.”
ResultIvanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 1×
“Th17 cells were identified as a lineage of the CD4 Th subpopulation (12, 13).”
BackgroundIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-23, a critical inducer of experimental autoimmune encephalitis and collagen-induced arthritis (15, 16), promotes the development of Th17 cells in vivo (17).”
BackgroundVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · cited 1×
“IL-23, a critical inducer of experimental autoimmune encephalitis and collagen-induced arthritis (15, 16), promotes the development of Th17 cells in vivo (17).”
BackgroundDevelopment, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Reciprocal T H 17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid
Mucida, D., Park, Y., Kim, G., Turovskaya, O., Scott, I., Kronenberg, M., & Cheroutre, H. (2007) · Science · doi:10.1126/science.1145697 · Cited by 1,982 · cited 1×
“The combination of TGF- and IL-6 promotes the differentiation of Th17 cells and inhibits Treg cell differentiation in mice (18–20), whereas TGF- plus retinoic acid inhibits Th17 cell differentiation and promotes Treg cells (21).”
BackgroundTGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Zhou, L., Lopes, J. E., Chong, M. M. W., Ivanov, I. I., Min, R., Victora, G. D., Shen, Y., Du, J., Rubtsov, Y. P., Rudensky, A. Y., et al. (2008) · Nature · doi:10.1038/nature06878 · Cited by 1,863
Phenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 2×
“S4), consistent with the phenotype of memory T cells (28).”
BackgroundResultLiyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Manel, N., Unutmaz, D., & Littman, D. R. (2008) · Nature Immunology · doi:10.1038/ni.1610 · Cited by 1,291
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018 · cited 2×
“the basis of IL-23 mRNA expression (5).”
BackgroundSutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010 · cited 1×
“IL-1 has also been shown to play a critical role in murine Th17 differentiation (22).”
BackgroundInnate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942 · cited 2×
“Because inflammation has been linked to cancer development and disease progression (27), it is reasonable to propose that Th17 cells may be present in the tumor microenvironment, where proinflammatory cytokines such as IL-1, IL-6, and IL-23 could be produced by tumor cells and tumor-infiltrating immune cells.”
BackgroundVolpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupé, P., Barillot, E., & Soumelis, V. (2008) · Nature Immunology · doi:10.1038/ni.1613 · Cited by 938
IL-21 and TGF-β are required for differentiation of human TH17 cells
Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., Kuchroo, V. K., & Hafler, D. A. (2008) · Nature · doi:10.1038/nature07021 · Cited by 927
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Amadi-Obi, A., Yu, C.-R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., & Egwuagu, C. E. (2007) · Nature Medicine · doi:10.1038/nm1585 · Cited by 865
Understanding the IL-23–IL-17 immune pathway
McKenzie, B. S., Kastelein, R. A., & Cua, D. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.003 · Cited by 766 · cited 1×
“IL-23, a critical inducer of experimental autoimmune encephalitis and collagen-induced arthritis (15, 16), promotes the development of Th17 cells in vivo (17).”
BackgroundTran, D. Q., Ramsey, H., & Shevach, E. M. (2007) · Blood · doi:10.1182/blood-2007-06-094656 · Cited by 743
van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W., Muller, F. J., Hommes, D. W., Zaat, S. A. J., Kapsenberg, M. L., & de Jong, E. C. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.013 · Cited by 518 · cited 1×
“Importantly, our data and another recent study (23) demonstrate the differentiation of naı̈ve T cells to Th17 cells, and two other studies reported the failure to induce Th17 cells from naı̈ve T cells when monocytes or dendritic cells were stimulated with various TLR and NOD2 ligands (26, 37).”
ResultTumor-Specific Human CD4+ Regulatory T Cells and Their Ligands
Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., & Wang, R.-F. (2004) · Immunity · doi:10.1016/s1074-7613(03)00359-5 · Cited by 515
Self-citationKryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A., & Zou, W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6730 · Cited by 416
Wang, H. Y., & Wang, R.-F. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.02.004 · Cited by 325 · cited 1×
“Treg cells significantly suppress immune responses, thus inducing immune tolerance at tumor sites (3), whereas Th17 cells have been linked to both autoimmune diseases and cancer (4–6).”
BackgroundSelf-citationOdunsi, K., Qian, F., Matsuzaki, J., Mhawech-Fauceglia, P., Andrews, C., Hoffman, E. W., Pan, L., Ritter, G., Villella, J., Thomas, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703342104 · Cited by 270 · cited 1×
“A growing body of evidence suggests that CD4 T-helper (Th) cells play a central role in initiating and maintaining immune responses against cancer (1, 2).”
BackgroundSelf-citationThe role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
Wang, R.-F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01896-8 · Cited by 266
Self-citationEvans, H. G., Suddason, T., Jackson, I., Taams, L. S., & Lord, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708426104 · Cited by 255 · cited 1×
“Importantly, our data and another recent study (23) demonstrate the differentiation of naı̈ve T cells to Th17 cells, and two other studies reported the failure to induce Th17 cells from naı̈ve T cells when monocytes or dendritic cells were stimulated with various TLR and NOD2 ligands (26, 37).”
ResultCritical role of IL‐2 and TGF‐β in generation, function and stabilization of Foxp3+CD4+ Treg
Horwitz, D. A., Zheng, S. G., Wang, J., & Gray, J. D. (2008) · European Journal of Immunology · doi:10.1002/eji.200738109 · Cited by 171
Wang, H. Y., Peng, G., Guo, Z., Shevach, E. M., & Wang, R.-F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2661 · Cited by 157
Self-citationExpression of IL-17 mRNA in Ovarian Cancer
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M., & Aono, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4618 · Cited by 152 · cited 1×
“In a previous study, IL-17 mRNA was detected in 11 (65%) of 17 ovarian tumors (36), but it is not clear whether IL-17 detected in tumor tissues is produced by Th17 cells.”
BackgroundImmunological profiling of a panel of human ovarian cancer cell lines
Carr, T. M., Adair, S. J., Fink, M. J., & Hogan, K. T. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0347-7 · Cited by 14 · cited 1×
“These results are consistent with a recent study showing that ovarian tumor cells secreted latent (inactive) TGF- but little or low active TGF(30).”
Result
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Increased IL17A expression in CRC correlates with increased expression of vascular endothelial growth factor (VEGF) and enhanced tumor blood vessel density (Liu et al., 2011b).”
BackgroundInfluentialSun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
The polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
“Accumulation of T H 17 cells in the tumour microenvironment has been reported in several types of cancer, as well as the expression of IL-6, IL-1β and TGFβ by tumour cells, which are key cytokines controlling T H 17 cell differentiation and proliferatio”
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
“Although IL-17–producing T cells have been found in increased numbers within certain tumors (Miyahara et al., 2008; Sfanos et al., 2008; Zhang et al., 2008), it remains controversial whether IL-17 promotes or inhibits cancer progression (Numasaki et al.”
BackgroundT Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
“Th17 cells and IL-17A expression have been found in various human tumors (Kryczek et al., 2007; Langowski et al., 2006; Miyahara et al., 2008; Sfanos et al., 2008; Zhang et al., 2008); however, their function in cancer immunity is unclear.”
Background
Metadata
- Authors
- Miyahara, Y., Odunsi, K., Chen, W., Peng, G., Matsuzaki, J., & Wang, R.-F.
- Affiliations
- Baylor College of Medicine (US)
- Roswell Park Comprehensive Cancer Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-10-07
- Volume
- 105
- Issue
- 40
- Pages
- 15505-15510
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2563129
- OpenAlex
- W1967824941
- Cited by
- 279
- References
- 39
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 7 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 18 · 2019: 11 · 2018: 7 · 2017: 14 · 2016: 12 · 2015: 14 · 2014: 20 · 2013: 28 · 2012: 30
- FWCI
- 10.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Institute
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- Th17 cells, IL-17, ovarian cancer, CD4+ T cells, tumor microenvironment, IL-1β, interleukin-6, IL-23, TGF-beta, TNF-α, anti-IL-1 therapy, IL-6 inhibition, T cell differentiation
- MeSH terms
- Cells, Cultured, Female, Humans, Ovarian Neoplasms, CD4-Positive T-Lymphocytes, Interleukin-6, T-Lymphocyte Subsets, Interleukin-17, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.